These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Severe metabolic alkalosis. Amundson DE; Diamant J South Med J; 1994 Feb; 87(2):275-7. PubMed ID: 8115901 [TBL] [Abstract][Full Text] [Related]
3. Severe metabolic alkalosis due to pyloric obstruction: case presentation, evaluation, and management. McCauley M; Gunawardane M; Cowan MJ Am J Med Sci; 2006 Dec; 332(6):346-50. PubMed ID: 17170625 [TBL] [Abstract][Full Text] [Related]
4. Acetazolamide for the management of chronic metabolic alkalosis in neonates and infants. Tam B; Chhay A; Yen L; Tesoriero L; Ramanathan R; Seri I; Friedlich PS Am J Ther; 2014; 21(6):477-81. PubMed ID: 23011176 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy of acetazolamide treatment of patients with hypercapnia and superimposed metabolic alkalosis]. Prieto de Paula JM; Villamandos Nicás V; Cancelo Suárez P; del Portillo Rubí A; Guillem Ares E; Prada Mínguez A; Sanz de la Fuente H Rev Clin Esp; 1997 Apr; 197(4):237-40. PubMed ID: 9254398 [TBL] [Abstract][Full Text] [Related]
6. Metabolic Alkalosis in the Pediatric Patient: Treatment Options in the Pediatric ICU or Pediatric Cardiothoracic ICU Setting. Tobias JD World J Pediatr Congenit Heart Surg; 2020 Nov; 11(6):776-782. PubMed ID: 33164684 [TBL] [Abstract][Full Text] [Related]
7. Acetazolamide: a second wind for a respiratory stimulant in the intensive care unit? Heming N; Urien S; Faisy C Crit Care; 2012 Aug; 16(4):318. PubMed ID: 22866939 [TBL] [Abstract][Full Text] [Related]
8. Novel use of acetazolamide in the treatment of rhabdomyolysis-induced myoglobinuric renal failure. Davidov T; Hong JJ; Malcynski JT J Trauma; 2006 Jul; 61(1):213-5. PubMed ID: 16832275 [No Abstract] [Full Text] [Related]
9. Clinical efficacy and indication of acetazolamide treatment on sleep apnea syndrome. Inoue Y; Takata K; Sakamoto I; Hazama H; Kawahara R Psychiatry Clin Neurosci; 1999 Apr; 53(2):321-2. PubMed ID: 10459724 [TBL] [Abstract][Full Text] [Related]
10. Acetazolamide therapy for hypochloremic metabolic alkalosis in pediatric patients with heart disease. Moffett BS; Moffett TI; Dickerson HA Am J Ther; 2007; 14(4):331-5. PubMed ID: 17667206 [TBL] [Abstract][Full Text] [Related]
12. Abolition of pentagastrin-stimulated alkaline tide using the carbonic anhydrase inhibitor acetazolamide. Regev A; Drori R; Fraser GM; Niv Y Isr Med Assoc J; 2001 Apr; 3(4):247-50. PubMed ID: 11344834 [TBL] [Abstract][Full Text] [Related]
13. Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study. Shahidzadeh R; Opekun A; Shiotani A; Graham DY Helicobacter; 2005 Apr; 10(2):136-8. PubMed ID: 15810944 [TBL] [Abstract][Full Text] [Related]
14. Acetazolamide therapy evaluation in haemorrhagic stroke. Popa G; Amaireh M; Dinu M; Jipescu I; Alaicescu M; Stănescu A; Nistorescu A Rom J Neurol Psychiatry; 1995; 33(2):145-55. PubMed ID: 7547378 [TBL] [Abstract][Full Text] [Related]
15. Metabolic alkalosis in the patient with uremia. Quintanilla A; Singer I Am J Kidney Dis; 1991 May; 17(5):591-5. PubMed ID: 2024663 [No Abstract] [Full Text] [Related]